Absence of APOL1 risk variants protects against HIV-associated nephropathy in the Ethiopian population.
about
The APOL1 genotype of African American kidney transplant recipients does not impact 5-year allograft survivalAPOL1 and nephropathy progression in populations of African ancestryAPOL1 kidney risk alleles: population genetics and disease associationsUpdate on current management of chronic kidney disease in patients with HIV infectionThe African diaspora: history, adaptation and healthPopulation ancestry and genetic risk for diabetes and kidney, cardiovascular, and bone disease: modifiable environmental factors may produce the curesAPOL1 renal risk variants have contrasting resistance and susceptibility associations with African trypanosomiasis.APOL1 risk variants enhance podocyte necrosis through compromising lysosomal membrane permeability.Research capacity. Enabling the genomic revolution in Africa.Gene-gene and gene-environment interactions in apolipoprotein L1 gene-associated nephropathy.APOL1 genetic variants, chronic kidney diseases and hypertension in mixed ancestry South Africans.Exon 4-encoded sequence is a major determinant of cytotoxicity of apolipoprotein L1The new era of APOL1-associated glomerulosclerosis.Translational Genomics in Low- and Middle-Income Countries: Opportunities and Challenges.Sequencing rare and common APOL1 coding variants to determine kidney disease risk.APOL1 Risk Variants Are Strongly Associated with HIV-Associated Nephropathy in Black South AfricansIdentifying Darwinian selection acting on different human APOL1 variants among diverse African populations.Pharmacogenomic implications of the evolutionary history of infectious diseases in AfricaRenoprotection and the Bardoxolone Methyl Story - Is This the Right Way Forward? A Novel View of Renoprotection in CKD Trials: A New Classification Scheme for Renoprotective Agents.The impact of APOL1, CAV1, and ABCB1 gene variants on outcomes in kidney transplantation: donor and recipient effects.APOL1 nephropathy: from gene to mechanisms of kidney injury.Genetic risk variants for membranous nephropathy: extension of and association with other chronic kidney disease aetiologies.HIV-associated nephropathy: a diagnosis in evolution.HIV-Associated Nephropathy in Africa: Pathology, Clinical Presentation and Strategy for Prevention.Kidney disease in the setting of HIV infection: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.Most ApoL1 Is Secreted by the Liver.APOL1 variants and kidney disease in people of recent African ancestry.An African perspective on the genetic risk of chronic kidney disease: a systematic reviewMixed Ancestry and Disease Risk Transferability
P2860
Q24594836-8D06E675-E62F-4FEE-91C8-CB70500881B0Q27022275-019D3114-FEE2-48B2-9AE4-BA84EBA01976Q27024261-925E17A3-1D28-46EF-9F10-A36414562C31Q27691460-0BE5CCEB-D485-4228-B737-21CFC9A12602Q28075805-E8512C57-99FF-49CE-B8A7-6A7751AFFF6BQ28391758-9D4C6B60-A399-479D-9272-E9B4F6116CD3Q33866444-59E33341-78DE-4952-91BD-8B12A29FD132Q34001289-B594A9AA-F6FB-458A-B880-93ECB464160AQ34068017-BB1BB8B5-CD96-49A9-8864-86B73ACC16F0Q34455119-0A95A960-07E0-4170-8BF1-6032006095A5Q35674836-5D221455-24BD-4362-83B1-31FED94015FFQ35813345-8E7DA0E8-E333-42BD-B8C5-B84F974A820CQ35861466-23E2CB39-FE3E-479A-BE9B-5947F7E9AF66Q35888017-222FD34B-829A-4695-8C7F-1E4EB150637AQ36113212-0ABA1193-B544-4E8C-B3D3-82E521930CA7Q36223249-742D75D3-4726-4E2D-A7F0-67EA92B6E9F8Q37010357-44AD5AAF-A6EE-4453-8CBD-0A9A6EBFAD67Q37737731-6A6FBD92-0535-4E5D-9339-182E5866CE92Q38107939-F63BC53F-08A4-48B8-B4E9-1119DFE49D54Q38113083-F180CF6B-1233-41C5-A03C-C2305675DF63Q38308481-D13387AA-B17F-4EF6-84BF-90E5D9AED887Q40687484-8B3B4496-B31B-4ECF-AC52-28D695E0E9DBQ42348818-E121C3AE-409E-41C8-84A0-D1D731D8BA5EQ46180374-50B06B29-BE03-4630-A9E2-6BABF3ABC811Q48507049-9C9E934A-7611-48DB-8F2E-6CEF1A063CC1Q51278220-B102A609-22EC-4F7A-826A-465BF5E4689CQ51492603-26F6E2F7-860C-4486-A857-8674D74A9FFDQ57809466-80E7A476-8DD4-4950-B394-C63977FEC784Q59192511-9E6E9242-C114-470A-902B-90BA785C2552
P2860
Absence of APOL1 risk variants protects against HIV-associated nephropathy in the Ethiopian population.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Absence of APOL1 risk variants ...... y in the Ethiopian population.
@en
Absence of APOL1 risk variants ...... y in the Ethiopian population.
@nl
type
label
Absence of APOL1 risk variants ...... y in the Ethiopian population.
@en
Absence of APOL1 risk variants ...... y in the Ethiopian population.
@nl
prefLabel
Absence of APOL1 risk variants ...... y in the Ethiopian population.
@en
Absence of APOL1 risk variants ...... y in the Ethiopian population.
@nl
P2093
P2860
P356
P1476
Absence of APOL1 risk variants ...... y in the Ethiopian population.
@en
P2093
Carcom Maor
Dawit Wolday
Doron M Behar
Eduardo Shahar
Eynat Kedem
Gamal Hassoun
Karl Skorecki
Saharon Rosset
Shimon Pollack
P2860
P304
P356
10.1159/000332378
P577
2011-10-03T00:00:00Z